Quantitative trait locus for protein C in a family with thrombophilia

Michael W. T. Tanck; Iris M. Wichers; Joost C. M. Meijers; Harry R. Büller; Pieter H. Reitsma; Saskia Middeldorp

doi:10.1160/TH10-06-0383

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2011; 105(01): 199-201
DOI: 10.1160/TH10-06-0383

Letters to the Editor

Schattauer GmbH

Quantitative trait locus for protein C in a family with thrombophilia

Authors

Michael W. T. Tanck

¹Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Am -sterdam, The Netherlands
Iris M. Wichers

²Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, The Netherlands
Joost C. M. Meijers

²Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, The Netherlands
Harry R. Büller

²Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, The Netherlands
Pieter H. Reitsma

³Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Saskia Middeldorp

⁴Department of Clinical Epidemiology and Department of General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands

Abstract

Full Text

References

References
1 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-1173.
2 Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. Thromb Haemost 2009; 102: 360-370.
3 Wichers IM, Tanck MW, Meijers JC. et al. Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia. Thromb Haemost 2009; 101: 465-470.
4 Segers O, Van Oerle R, Ten Cate H. et al. Thrombin generation as an intermediate phenotype for venous thrombosis. Thromb Haemost 2010; 103: 114-122.
5 Rosing J, Tans G, Nicolaes GA. et al. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. Brit J Haematol 1997; 97: 233-238.
6 Sandset PM, Abildgaard U, Pettersen M. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res 1987; 47: 389-400.
7 Weber JL, Broman KW. Genotyping for human whole-genome scans: past, present and future. Adv Genet 2001; 42: 77-96.
8 Lange K, Cantor R, Horvath S. et al. Mendel version 4.0: a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets. Am J Hum Genet 2001; 69: A1886.
9 Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-1211.
10 Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
11 Almasy L, Dyer TD, Blangero J. Bivariate quantitative trait linkage analysis: pleiotropy versus coincident linkages. Genet Epidemiol 1997; 14: 953-958.
12 Buil A, Soria JM, Souto JC. et al. Protein C levels are regulated by a Quantitative trait locus on chromo-some 16. Arterioscl Throm Vas 2004; 24: 1321-1325.
13 Kent WJ, Sugnet CW, Furey TS. et al. The human genome browser at UCSC. Genome Res 2002; 12: 996-1006.
14 Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. P Natl Acad Sci USA 1981; 78: 2249-2252.
15 Spek CA, Greengard JS, Griffin JH. et al. Two mutations in the promotor region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites. J Biol Chem 1995; 270: 24216-24221.
16 Reiner AP, Carty CL, Jenny NS. et al. PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study. J Thromb Haemost 2008; 06: 1625-1632.
17 Centelles MN, Puy C, Lopez-Sagaseta J. et al. Blocking endothelial protein C receptor (EPCR) accelerates thrombus development in vivo . Thromb Haemost 2010; 103: 1239-1244.